The functional effect of beta blockers vs vasodilators in hypertension treatment

Journal of Clinical and Basic Cardiology

Volumn 11, Issue 1-4, 2008, Pages 8-10

  Klainman, E ^a,b   Starobin, D ^b   Wishnitzer, R ^b   Yarmolovsky, A ^b   Fink, G ^b  

^a Gefen Cardiac Health Center   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Cardiopulmonary exercise test; Hypertension treatment; Physiological effect of beta blockers and vasodilators

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CILAZAPRIL; DILTIAZEM; ENALAPRIL; LOSARTAN; METOPROLOL; NIFEDIPINE; OXYGEN; RAMIPRIL; VALSARTAN; VASODILATOR AGENT; VERAPAMIL;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; BLOOD PRESSURE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; LUNG GAS EXCHANGE; MALE; MONITORING; OXYGEN CONSUMPTION; PHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STUDENT T TEST; VALIDATION STUDY;

EID: 57349188389     PISSN: 15612775     EISSN: 16809386     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using beta-blockers: A critical review of evidence. J Am Coll Cardiol 2007; 50: 563-72.
2. Lindholm LH, Carlberg B, Samuelsson O. Should beta-blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366: 1545-53.
3. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systemic review. JAMA 1998; 279: 1903-7.
4. Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systemic review and meta-analysis. J Hypertens 2006; 24: 2131-41.
5. Bangalore S, Parker S, Grossman E, Messerli FH. A meta-analysis of 94,492 pts with hypertension treated with beta-blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol 2007; 100: 1254-62.
6. Beaver WL, Wasserman K, Whipp B. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020-7.
7. nd Annual Cardiovascular Conference, Hawaii, USA; August 2007.
8. Howard PA. An ongoing debate: Should beta-blockers be used for primary hypertension? Hosp Pharm 2007; 42: 22-6, 86.
9. Rudd P. Review: Beta blockers are less effective than other antihypertensive drugs for reducing risk of stroke in primary hypertension. Evid Based Med 2006; 11: 85.
10. Prisant LM. Should beta-blockers be used in the treatment of hypertension in the elderly? J Clin Hypertens (Greenwich) 2002; 4: 286-94.
11. Paran E, Anson O, Neumann L. The effect of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients. Am J Hypertens 1996; 9: 1206-13.
12. Dzau VJ. Evaluation of the clinical management of hypertension: Emerging role of "specific" vasodilators as initial therapy. Am J Med 1987; 82 (Suppl): 36-43.
13. Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation 2004; 110: e27-e31.
14. Savolainen A, Keto P, Poutanen VP, Hekali P, Standertskjold-Nordenstam CG, Rames A, Kupari M. Effect of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension. J Cardiovasc Pharmacol 1996; 27: 99-104.
15. Kraft KA, Arena R, Arrowood JA, Fei DY. High aerobic capacity does not attenuate aortic stiffness in hypertensive subjects. Am Heart J 2007; 154: 976-82.